Medifast Unit To Fork Over $4M To FTC Over Weight-Loss Ads
Jason Pharmaceuticals said the FTC had expressed concern that some of its claims did not meet current standards for substantiation, and voiced a particular objection to the company's use of the phrase "up to" in connection with its ads' weight loss claims.
Under the proposed consent agreement, the company agreed to...
Already a subscriber? Click here to login